Generating live attenuated vaccines through repeated passages in cells and animals has been standard procedure for more than a century. A more targeted approach may lie on the horizon (pages 154–161).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Ris-Vicari
References
Minor, P.D. Nat. Rev. Microbiol. 2, 473–482 (2004).
Vignuzzi, M., Wendt, E. & Andino, R. Nat. Med. 14, 154–161 (2008).
Drake, J.W. Ann. NY Acad. Sci. 870, 100–107 (1999).
Vignuzzi, M., Stone, J.K., Arnold, J.J., Cameron, C.E. & Andino, R. Nature 439, 344–348 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Minor, P. A deader vaccine?. Nat Med 14, 120–121 (2008). https://doi.org/10.1038/nm0208-120
Issue Date:
DOI: https://doi.org/10.1038/nm0208-120
